J Aubrey Bottoms
Ph.D., ABPP-CN
Dr. Bottoms is a Board Certified Clinical Neuropsychologist and the Director of the Neuropsychology, Behavioral Health, and Wellness division at DENT. She is also well versed in the evaluation of adult and pediatric cognitive and psychiatric symptoms of post-concussion disorder.
Dr. Bottoms is located at DENT Tower in Amherst.
Throughout her education and training at the University at Buffalo, Brown, Tulane, and Penn State, she has acquired specialized knowledge of the neuropsychological sequelae of several neurologic disorders including neuro-oncology, memory disorders such as mild cognitive impairment and various dementias, epilepsy, stroke, and multiple sclerosis.
SPECIALITIES
- Memory Disorders
- Neuropsychology
- Post Concussion/Head Injury
- Perinatal Mental Health
- Infertility
Board Certifications
- Clinical Neuropsychology
- Perinatal Mental Health
Education
Medical / Graduate Education
University at Buffalo
Internship
Brown Medical School
Residency
University at Buffalo School of Medicine & Biomedical Sciences
Fellowship
Neuropsychology; University at Buffalo School of Medicine & Biomedical Sciences
Meet Our Team!
Open Clinical Trials
ENVISION
ENVISION Trial The objective of this study is to verify the clinical benefit of monthly doses of aducanumab in slowing cognitive and functional impairment as …
Signal – AD
Signal- AD Trial The purpose of the study is to investigate safety, tolerability, the effects on cognition and brain metabolism of pepinemab in people with …
ADNI4 Trial
ADNI4 Trial The ADNI4 is multi-center, a non-randomized, natural history, non-treatment study. 1,150 participants will be enrolled across three cohorts: cognitively normal (CN), mild cognitive …
ADNI3 Trial
ADNI3 Trial Dent is taking part in an observational study called the ADNI3 Trial. This historic study of brain aging could help change the future …
PIONEER T3D: Clinical Study Evaluating Efficacy and Safety of T3D-959 in Mild-to-moderate Alzheimer’s Disease Subjects
PIONEER T3D: Clinical Study Evaluating Efficacy and Safety of T3D-959 in Mild-to-moderate Alzheimer’s Disease Subjects Inclusion Criteria Age 55-90 years Have a reliable study partner, …
Want to participate in a study?
Fill out the form below and one of our Research Coordinators will be in contact with you as soon as possible. If we currently do not have a study that is currently available for you, we will add you to our database for future studies.
Subscribe To Our Newsletter
Sign up to receive email updates on announcements, new services added, company updates & more!
Call us to schedule an appointment
Our entire team, from customer service to patient providers, is focused on the central mission to deliver superior clinical care, advanced neurodiagnostics, clinical research and education that will assist our patients in maximizing their quality of life. We strive to exceed the expectations of our patients, clinical partnerships and community partners.